During the past decade, Yuvell conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yuvell" #1 collaborator was "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Yuvell" are "Correction of Nasolabial Folds" (2 trials), "Lateral Canthal Lines" (1 trials), "Midface Volume Deficit" (1 trials), "Moderate to Severe Nasolabial Folds" (1 trials) and "Perioral Rhytids" (1 trials). Many other conditions were trialed in "Yuvell" in a lesser frequency.

Most popular intervention types in "Yuvell" are "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dermal filler for midface deficit" (1 trials), "Princess FILLER Lidocaine" (1 trials), "Princess® RICH" (1 trials), "Saypha Volume Lidocaine" (1 trials) and "THIODERM STRONG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yuvell" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Yuvell". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Yuvell, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yuvell, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".